首页> 外文期刊>British journal of ophthalmology >Glaucoma management in the era of artificial intelligence
【24h】

Glaucoma management in the era of artificial intelligence

机译:人工智能时代的青光眼管理

获取原文
获取原文并翻译 | 示例
       

摘要

Glaucoma is a result of irreversible damage to the retinal ganglion cells. While an early intervention could minimise the risk of vision loss in glaucoma, its asymptomatic nature makes it difficult to diagnose until a late stage. The diagnosis of glaucoma is a complicated and expensive effort that is heavily dependent on the experience and expertise of a clinician. The application of artificial intelligence (AI) algorithms in ophthalmology has improved our understanding of many retinal, macular, choroidal and corneal pathologies. With the advent of deep learning, a number of tools for the classification, segmentation and enhancement of ocular images have been developed. Over the years, several AI techniques have been proposed to help detect glaucoma by analysis of functional and/or structural evaluations of the eye. Moreover, the use of AI has also been explored to improve the reliability of ascribing disease prognosis. This review summarises the role of AI in the diagnosis and prognosis of glaucoma, discusses the advantages and challenges of using AI systems in clinics and predicts likely areas of future progress.
机译:青光眼是视网膜神经节细胞不可逆转的损伤。虽然早期干预可以最小化青光眼视力丧失的风险,但其无症状的性质使得难以诊断到晚期。青光眼的诊断是一种复杂且昂贵的努力,严重依赖于临床医生的经验和专业知识。人工智能(AI)算法在眼科中的应用提高了我们对许多视网膜,黄斑,脉络膜和角膜病理的理解。随着深度学习的出现,已经开发了许多用于分类,分割和眼部图像增强的工具。多年来,已经提出了几种AI技术通过分析眼睛的功能和/或结构评估来帮助检测青光眼。此外,还探讨了AI的使用,以提高疾病预后的可靠性。本综述总结了AI在青光眼诊断和预后的作用,探讨了在诊所中使用AI系统的优缺点,并预测未来进展的可能领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号